Skip to content
Rio de Janeiro · São Paulo · Salvador — matters across Brazil
Bruno Marcelos — Escritório de Advocacia

Pauta Regulatória · Daily brief

No. 214

Automatically translated from the Portuguese edition, which prevails in case of discrepancy. Ler em português

Federal Official Gazette

No updates.

ANS news

No updates.

Open public consultations

  • CP 175. Subject: comments and suggestions on the preliminary recommendations not to incorporate the technologies covered by UAT No. 199 – Cholangioscopy, UAT No. 200 – Next-generation sequencing (NGS) panel and UAT No. 206 – Tepotinib hydrochloride. Deadline: Aug 12, 2026 to Aug 31, 2026

Scheduled public hearings

There are no public hearings scheduled.

Open public calls for input

There is no open public call for input.

Open public calls

There are no open public calls

Other news

ANS public call on discount cards triples volume of contributions

Source: futurodasaude.com.br · read the full article

STJ: health plan operator must maintain treatment of child with ADHD until a new plan is contracted

Source: jota.info · read the full article

Hapvida: ANS prevents price increase or termination of up to 1 million plans

Source: metropoles.com · read the full article

Sources: Federal Official Gazette (DOU) and the ANS website. Press items link to the original article. This brief is for information only and does not constitute legal advice.